ACE gene polymorphism and antihypertensive efficacy of losartan in patients with primary hypertension
暂无分享,去创建一个
M. Kaczmarczyk | A. Januszewicz | J. Janas | A. Prejbisz | A. Ciechanowicz | I. Gorący | G. Adler | A. Bińczak-Kuleta | M. Makowiecka-ciesla | A. Kubaszek
[1] Donna K Arnett,et al. Pharmacogenetics of antihypertensive treatment. , 2006, Vascular pharmacology.
[2] U. Yasar,et al. CYP2C9 genetic variants and losartan oxidation in a Turkish population , 2004, European Journal of Clinical Pharmacology.
[3] P. Insel,et al. Pharmacogenetics of hypertension treatment: a structured review. , 2003, Pharmacogenetics.
[4] H. Parving,et al. Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? , 2003, Diabetes care.
[5] H. Melhus,et al. The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial , 2002, Journal of hypertension.
[6] H. Parving,et al. Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype? , 2002, Kidney international.
[7] M. Borggrefe,et al. Variants of the CYP11B2 gene predict response to therapy with candesartan. , 2002, European journal of pharmacology.
[8] Erik Eliasson,et al. Pharmacokinetics of losartan and its metabolite E‐3174 in relation to the CYP2C9 genotype , 2002, Clinical pharmacology and therapeutics.
[9] H. Melhus,et al. Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients , 2001, Journal of hypertension.
[10] M. Ingelman-Sundberg,et al. Role of CYP2C9 polymorphism in losartan oxidation. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[11] N. Martell,et al. Renin–angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients , 2005, The Pharmacogenomics Journal.
[12] J. Nurnberger,et al. A non-organic and non-enzymatic extraction method gives higher yields of genomic DNA from whole-blood samples than do nine other methods tested. , 1992, Journal of biochemical and biophysical methods.